Published 3 years ago

Russia's Sputnik V vaccine 97.6% effective in real-world study

Summary by Yahoo News

Russian scientists have found the Sputnik V vaccine 97.6% effective against COVID-19 in a "real-world" assessment based on data from 3.8 million people, Moscow's Gamaleya Institute and the Russian Direct Investment Fund said on Monday. The new effectiveness rate is higher than the 91.6% rate outlined in results from a large-scale trial of Sputnik V that was published in The Lancet medical journal earlier this year, and compar

0 Articles

All

Left

Center

Right

Yahoo News

UPDATE 1-Russia's Sputnik V vaccine 97.6% effective in real-world study

3 years ago·Los Angeles, United States

Read Full Article

Reuters

Russia's Sputnik V vaccine 97.6% effective in real-world study

Russian scientist Denis Logunov, a lead developer of the Sputnik V coronavirus vaccine, said on Friday that the shot had proven itself 97.6% effective against COVID-19 in a real-world assessment, based on data from 3.8 million people.

3 years ago·United Kingdom

Read Full Article

TASS [🇷🇺-affiliated]

Austrian government decides to buy Russian Sputnik V vaccine, chancellor says

The jab will go into circulation following the European Medicines Agency approval

3 years ago·Moscow, Russian Federation

Read Full Article

The Straits Times

Russia's Sputnik V vaccine 97.6% effective in real-world study: Scientist

This is higher than the 91.6 per cent rate outlined in results from a large-scale trial published in The Lancet earlier this year.. Read more at straitstimes.com.

3 years ago·Singapore

Read Full Article

National Post

Russia's Sputnik V vaccine 97.6% effective in real-world study

MOSCOW — Russian scientists have found the Sputnik V vaccine 97.6% effective against COVID-19 in a “real-world” assessment based on data from 3.8 million…

3 years ago·Canada

Read Full Article

Live Mint

Sputnik V Covid vaccine 97.6% effective in real-world study: Russian scientist

The new effectiveness rate is higher than the 91.6% rate outlined in results from a large-scale trial of Sputnik V and published in The Lancet medical journal earlier this year

3 years ago·New Delhi, India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.